Back to Search Start Over

Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.

Authors :
Erikka Loftfield
Thomas R O'Brien
Ruth M Pfeiffer
Charles D Howell
Ron Horst
Ludmila Prokunina-Olsson
Stephanie J Weinstein
Demetrius Albanes
Timothy R Morgan
Neal D Freedman
Source :
PLoS ONE, Vol 11, Iss 11, p e0166036 (2016)
Publication Year :
2016
Publisher :
Public Library of Science (PLoS), 2016.

Abstract

Higher vitamin D status was not beneficially associated with responses to therapy; if anything, patients with higher vitamin D concentrations were less likely to attain SVR. Our data do not support a role for vitamin D supplementation as an adjuvant therapy for HCV.

Subjects

Subjects :
Medicine
Science

Details

Language :
English
ISSN :
19326203
Volume :
11
Issue :
11
Database :
Directory of Open Access Journals
Journal :
PLoS ONE
Publication Type :
Academic Journal
Accession number :
edsdoj.f65d4374ddc040e6a38f1ed291a0a8f4
Document Type :
article
Full Text :
https://doi.org/10.1371/journal.pone.0166036